Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)
Sponsor: Humanity & Health Medical Group Limited
Summary
To Identify the collected cases who can stop NAs safely with satisfactory clinical outcome including sustain viral remission and HBsAg clearance among chronic hepatitis B(CHB) patients.
Official title: Virological Response After Cessation of Long Term Anti-HBV Nucleos(t)Ide Analogues (NAs) vs. Keeping on NAs Among Chronic Hepatitis B (CHB) Patients
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
2000
Start Date
2018-12-01
Completion Date
2025-12-31
Last Updated
2025-03-24
Healthy Volunteers
No
Conditions
Interventions
Stop current treatment (anti-HBV neucleos(t)ides)
Stop the current anti-HBV neucleos(t)ides treatment among the CHB patients who meet the criteria the stopping rule of long term treatment.
Keep current treatment (anti-HBV neucleos(t)ides)
Keep the current anti-HBV neucleos(t)ides treatment among the CHB patients who meet the criteria the stopping rule of long term treatment.
Locations (1)
Humanity & Health Research Centre
Hong Kong, Hong Kong SAR, Hong Kong